Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Lupus Nephritis”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Testing effectiveness (Phase 2)Looking for participantsNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Testing effectiveness (Phase 2)Looking for participantsNCT06947460
What this trial is testing

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension+1 more
Beijing GoBroad Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT07328581
What this trial is testing

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
iCell Gene Therapeutics 20
Not applicableLooking for participantsNCT06902844
What this trial is testing

Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Tongji Hospital 6
Very early researchNot Yet RecruitingNCT07412210
What this trial is testing

Safety and Efficacy of ES-NK Cell Injection in the Treatment of Refractory Lupus Nephritis: an Early Clinical Study

Who this might be right for
Systemic Lupus Erythenlatosus Nephritis
Shanghai Jiao Tong University School of Medicine 9
Early research (Phase 1)WithdrawnNCT06752876
What this trial is testing

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP)

Who this might be right for
Systemic Lupus ErythematosusLupusLupus Erythematosus+1 more
Caribou Biosciences, Inc.
Early research (Phase 1)Looking for participantsNCT06943937
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis (LN)Immune Thrombocytopenia (ITP)
China Immunotech (Beijing) Biotechnology Co., Ltd. 36
Early research (Phase 1)Looking for participantsNCT06676631
What this trial is testing

NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis

Who this might be right for
Refractory Systemic Lupus ErythematosusRefractory Lupus Nephritis
Guangdong Provincial People's Hospital 18
Very early researchNot Yet RecruitingNCT07674147
What this trial is testing

RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSLE - Systemic Lupus ErythematosusSSc-Systemic Sclerosis+3 more
The Children's Hospital of Zhejiang University School of Medicine 30
Testing effectiveness (Phase 2)Ended earlyNCT05938725
What this trial is testing

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - World Health Organization (WHO) Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 6
Very early researchUnknownNCT05930314
What this trial is testing

CNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus

Who this might be right for
Refractory Systemic Lupus ErythematosusLupus NephritisImmune Thrombocytopenia
Peking Union Medical College Hospital 12
Early research (Phase 1)Active Not RecruitingNCT06544330
What this trial is testing

SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis
Synthekine 48
Early research (Phase 1)Active Not RecruitingNCT06265220
What this trial is testing

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IVRefractory Systemic Lupus Erythematosus+1 more
Artiva Biotherapeutics, Inc. 51
Testing effectiveness (Phase 2)Looking for participantsNCT06947473
What this trial is testing

Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension
Beijing GoBroad Hospital 45
Not applicableEnrolling By InvitationNCT07517536
What this trial is testing

CHT105 for the Treatment of Refractory Lupus Nephritis

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729826
What this trial is testing

C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard Therapy

Who this might be right for
Lupus Nephritis (LN)Systemic Lupus Erythematosus (SLE)Autoimmune Diseases
AbelZeta Inc. 50
Early research (Phase 1)Not Yet RecruitingNCT07729995
What this trial is testing

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erthematosus (SLE)Dermatomyositis (DM)+1 more
Luminary Therapeutics 94
Not applicableUnknownNCT03054545
What this trial is testing

Iguratimod as Treatment for Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
RenJi Hospital 30
Early research (Phase 1)Study completedNCT06064929
What this trial is testing

Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

Who this might be right for
Lupus Nephritis
HI-Bio, A Biogen Company 14
Next Page